| 000 | 01836 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516041148.0 | ||
| 264 | 0 | _c20120228 | |
| 008 | 201202s 0 0 eng d | ||
| 022 | _a1651-2006 | ||
| 024 | 7 |
_a10.3109/14017431.2011.583356 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJensen, Hanna | |
| 245 | 0 | 0 |
_aLevosimendan decreases intracranial pressure after hypothermic circulatory arrest in a porcine model. _h[electronic resource] |
| 260 |
_bScandinavian cardiovascular journal : SCJ _cOct 2011 |
||
| 300 |
_a307-15 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAnimals, Newborn |
| 650 | 0 | 4 |
_aBody Temperature _xdrug effects |
| 650 | 0 | 4 |
_aBrain _xdrug effects |
| 650 | 0 | 4 |
_aCirculatory Arrest, Deep Hypothermia Induced _xadverse effects |
| 650 | 0 | 4 |
_aHemodynamics _xdrug effects |
| 650 | 0 | 4 |
_aHydrazones _xadministration & dosage |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 |
_aIntracranial Pressure _xdrug effects |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aOxygen Consumption _xdrug effects |
| 650 | 0 | 4 |
_aPostoperative Complications _xetiology |
| 650 | 0 | 4 |
_aPyridazines _xadministration & dosage |
| 650 | 0 | 4 | _aSimendan |
| 650 | 0 | 4 | _aSwine |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aEija, Rimpiläinen | |
| 700 | 1 | _aTuomas, Mäkelä | |
| 700 | 1 | _aJussi, Mäkelä | |
| 700 | 1 | _aFredrik, Yannopoulos | |
| 700 | 1 | _aKirsi, Alestalo | |
| 700 | 1 | _aMatti, Pokela | |
| 700 | 1 | _aKai, Kiviluoma | |
| 700 | 1 | _aHannu, Tuominen | |
| 700 | 1 | _aVesa, Anttila | |
| 700 | 1 | _aTatu, Juvonen | |
| 773 | 0 |
_tScandinavian cardiovascular journal : SCJ _gvol. 45 _gno. 5 _gp. 307-15 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/14017431.2011.583356 _zAvailable from publisher's website |
| 999 |
_c20883865 _d20883865 |
||